Pfizer has announced a deal with AstraZeneca for exclusive over-the-counter (OTC) rights to market Nexium for approved indications in the United States, Europe and the rest of the world.

I take the over-the-counter Nexium 24HR, which is a 20 mg dose rather than the 40 mg prescription. I asked AstraZeneca, the maker of Nexium, to explain the differences between Nexium and Nexium ...

AstraZeneca has agreed to sell some of the rights to its drugs Nexium and Vimovo to Grünenthal for an upfront payment of $922 million. The move represents the biggest single investment to date ...